EVM
IONS icon

Eaton Vance Management’s Ionis Pharmaceuticals IONS Stock Holding History

Eaton Vance Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.13M Buy
70,682
+1,084
+2% +$45.7K ﹤0.01% 914
2022
Q2 		$2.58M Buy
69,598
+13,033
+23% +$491K ﹤0.01% 1001
2022
Q1 		$2.1M Buy
56,565
+28,873
+104% +$945K ﹤0.01% 1165
2021
Q4 		$843K Buy
27,692
+818
+3% +$25.7K ﹤0.01% 1208
2021
Q3 		$885K Sell
26,874
-200
-0.7% -$7.54K ﹤0.01% 1117
2021
Q2 		$1.08M Buy
27,074
+604
+2% +$23.7K ﹤0.01% 1155
2021
Q1 		$1.19M Hold
26,470
– – ﹤0.01% 1097
2020
Q4 		$1.5M Buy
26,470
+547
+2% +$27.3K ﹤0.01% 986
2020
Q3 		$1.23M Buy
25,923
+2,939
+13% +$163K ﹤0.01% 942
2020
Q2 		$1.35M Buy
22,984
+3,325
+17% +$185K ﹤0.01% 897
2020
Q1 		$929K Buy
19,659
+3
+0% +$167 ﹤0.01% 925
2019
Q4 		$1.19M Buy
19,656
+3
+0% +$179 ﹤0.01% 941
2019
Q3 		$1.18M Hold
19,653
– – ﹤0.01% 915
2019
Q2 		$1.26M Buy
19,653
+11,653
+146% +$824K ﹤0.01% 894
2019
Q1 		$649K Hold
8,000
– – ﹤0.01% 1019
2018
Q4 		$432K Hold
8,000
– – ﹤0.01% 1022
2018
Q3 		$413K Hold
8,000
– – ﹤0.01% 1058
2018
Q2 		$333K Sell
8,000
-8,000
-50% -$355K ﹤0.01% 1082
2018
Q1 		$706K Buy
+16,000
New +$813K ﹤0.01% 1033

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Eaton Vance Management's IONS Position: Q3 2022 in Review

Eaton Vance Management increased its Ionis Pharmaceuticals (IONS) stake by 1.6% in Q3 2022, buying an estimated $45.7K and bringing the position to 70,682 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Eaton Vance Management first reported a position in IONS in Q1 2018 and has held it in 19 quarters since. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Eaton Vance Management held 70,682 shares of Ionis Pharmaceuticals worth $3.13M as of Q3 2022.
  • Eaton Vance Management bought 1,084 Ionis Pharmaceuticals shares in Q3 2022, an estimated $45.7K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #914 holding.
  • Eaton Vance Management first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 19 quarters since.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.